Gross Profit On Sales Alterar Data
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Bayer EUR 5.53B 796M 2023-09
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eisai JPY 140.19B 12.82B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Exelixis USD 453.15M 1M 2023-09
Incyte USD 949.29M 84.66M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Takeda JPY 699.51B 38B 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12



Exelixis Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.